WAT · Earnings call · 2026Q2T · Full report
Supply Chain Localization
WATERS CORP /DE/ · 2026-08-04 · Importance 34 · Surprise 42 · In source text
Waters’ localized manufacturing program for flow instruments in China is underway and is expected to begin contributing to growth in the fourth quarter. The company plans to have its full flow-cytometry portfolio available locally in Q4, addressing prior portfolio gaps and improving competitiveness. Local production of FX and FXI instruments is also planned for China, supporting microbiology availability and market recovery. Management described localization as a durable advantage for the acquired businesses.
Key facts
- Localized manufacturing program for flow instruments expected to begin contributing to growth in Q4 2026
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | probable | — | Localized manufacturing program for flow instruments expected to begin contributing to growth in Q4 2026 |